Beyond CDR-grafting: Structure-guided humanization of framework and CDR regions of an anti-myostatin antibody
Author:
Affiliation:
1. Biomedicine Design, Pfizer Inc., Cambridge, MA, USA
2. Rare Disease Research Unit, Pfizer Inc., Cambridge, MA, USA
Publisher
Informa UK Limited
Subject
Immunology,Immunology and Allergy
Link
https://www.tandfonline.com/doi/pdf/10.1080/19420862.2016.1215786
Reference83 articles.
1. The therapeutic monoclonal antibody market
2. Frontier of therapeutic antibody discovery: The challenges and how to face them
3. Fully Human Therapeutic Monoclonal Antibodies
4. Improving the efficacy of antibody-based cancer therapies
Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Vaccine enhancement and improved immunogenicity using erythrocytes as carriers;Medical Hypotheses;2024-09
2. Generation of rabbit single-chain variable fragments with different physicochemical and biological properties by complementary determining region-grafting technology;Journal of Bioscience and Bioengineering;2024-08
3. 50 years of antibody numbering schemes: a statistical and structural evaluation reveals key differences and limitations;2024-07-10
4. Prospects for the computational humanization of antibodies and nanobodies;Frontiers in Immunology;2024-05-15
5. The rise of big data: deep sequencing-driven computational methods are transforming the landscape of synthetic antibody design;Journal of Biomedical Science;2024-03-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3